Cells inferred to be otherwise healthy CD34+CD38– stem/progenitor cells lacking the leukemic phenotype but with potential for leukemia initiation, termed “pre-LSCs” have been identified in patients with de novo AML. This evidence concerns the gene CD38 and acute myeloid leukemia.